The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

There’s no question that the wildly popular injectable weight-loss drugs help people drop pounds, lower heart-disease risk, ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent ...

PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support ...

SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Tirzepatide is approved by the Food and Drug Administration (FDA) for treating type 2 diabetes and obesity, akin to other GLP ...

FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...

NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...